Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 5/20 | 0.38 |
| ▸ | CA9 | Q16790 | 5/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.35 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.35 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25928 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL11583577 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL31229527 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL11552627 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL11554965 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL27017 | 1.00 | TTR (0.50) | TTRMGLLSMN1; SMN2CA12CA7 | |
| Hydrochloric Acid SCHEMBL11584373 | 0.96 | TTR (0.46) | TTRMGLLSMN1; SMN2CA12CA7 | |
| Hydrochloric Acid SCHEMBL15639418 | 0.96 | TTR (0.46) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL19209486 | 0.96 | TTR (0.46) | TTRMGLLSMN1; SMN2CA12CA7 | |
| SCHEMBL10599432 | 0.96 | MGLL (0.47) | TTRMGLLSMN1; SMN2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1072 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116096760-B | Hindered amine stabilized UV-active organopalladium catalyzed polycycloolefin compositions as optical materials | 住友电木株式会社 | 2024-08-02 | — | — | CN | claimed |
| US-11667731-B2 | Stabilized UV active organopalladium compounds as vinyl addition catalysts | PROMERUS, LLC (US) | 2023-06-06 | — | — | US | claimed |
| CN-116096760-A | Hindered amine stabilized UV-active organopalladium catalyzed polycycloolefin compositions as optical materials | 普罗米鲁斯有限责任公司 | 2023-05-09 | — | — | CN | claimed |
| US-20230038665-A1 | STABILIZED UV ACTIVE ORGANOPALLADIUM COMPOUNDS AS VINYL ADDITON CATALYSTS | PROMERUS, LLC (US) | 2023-02-09 | — | — | US | claimed |
| WO-2023278649-A1 | STABILIZED UV ACTIVE ORGANOPALLADIUM COMPOUNDS AS VINYL ADDITION CATALYSTS | PROMERUS, LLC (US) | 2023-01-05 | — | — | WO | claimed |
| WO-2022212367-A1 | STABILIZED BORON ANIONS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-10-06 | — | — | WO | claimed |
| US-10098974-B2 | Catalytic radiofluorination | THE GENERAL HOSPITAL CORPORATION (US) | 2018-10-16 | — | — | US | claimed |
| EP-2148836-B1 | METHOD FOR THE PREPARATION OF REACTIVE [18]F FLUORIDE | TRASIS S A (BE) | 2017-10-25 | — | — | EP | claimed |
| US-9550704-B2 | Method for synthesizing radiopharmaceuticals using a cartridge | FUTURECHEM CO., LTD. (KR) | 2017-01-24 | — | — | US | claimed |
| US-20150232392-A1 | METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE | FUTURECHEM CO., LTD. (KR) | 2015-08-20 | — | — | US | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5300439-A | Hydrophobic ionophore and reporter substance, hydrophilic polymer | MILES INC. (US) | 1994-04-05 | — | — | US | claimed |
| EP-0041175-B2 | ION SPECIFIC ANALYTICAL ELEMENT | MILES INC. (US) | 1993-06-09 | — | — | EP | claimed |
| EP-0125555-B1 | UNIFIED TEST MEANS FOR ION DETERMINATION | MILES INC. (US) | 1989-12-20 | — | — | EP | claimed |
| EP-0125554-B1 | ION TEST MEANS HAVING A HYDROPHILIC CARRIER MATRIX | MILES INC. (US) | 1988-07-27 | — | — | EP | claimed |
| US-4600566-A | Method of lithium isotope separation | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1986-07-15 | — | — | US | claimed |
| EP-0036554-B1 | DIAGNOSTIC AGENT FOR THE DETECTION OF KETONE BODIES | BEHRINGWERKE Aktiengesellschaft (DE) | 1985-06-05 | — | — | EP | claimed |
| US-4272435-A | Process for the preparation of azo compounds from amino compounds in the presence of a phase transfer catalyst | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-06-09 | — | — | US | claimed |
| US-4162269-A | BISULFITE ADDITION USING QUATERNARY AMMONIUM SALT, TERTIARY AMINE SALT, OR MACROCYCLIC POLYETHER AS CATALYST; DECOMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-07-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232392-A1 | METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE | ADCYAP1R1, PAICS, SSTR5 | TTR 2684/4885MGLL 446/4885SMN1; SMN2 4545/4885 |
| US-10098974-B2 | Catalytic radiofluorination | ARSA, STS, KCNK18 | TTR 900/4885MGLL 2628/4885SMN1; SMN2 2277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.